Antibiotic-Free Plasmid Stability via Toxin-Antitoxin Systems
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional recombinant bacterial manufacturing methods rely on antibiotics for selection and plasmid stability, leading to environmental and health issues, as well as inefficient and cumbersome processes.
Innovation Solution
A recombinant bacterial cell with an inactivated endogenous essential gene and an introduced copy of that gene linked to an inducible expression control sequence, allowing gene expression to depend on an inducer molecule, eliminating the need for antibiotics and simplifying the generation of producing bacterial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used for selection and plasmid stability, then transformed bacteria can be selected and plasmids can be kept stable, but environmental and health problems occur and multi-resistant pathogens are generated
Solution Approach 1:
The patent removes antibiotic selection markers and antibiotic dependency from the plasmid system. Instead of relying on antibiotic resistance genes for plasmid maintenance, the invention uses a toxin-antitoxin system where the antitoxin gene is encoded on the plasmid itself, eliminating the need for antibiotics while maintaining plasmid stability through biological control mechanisms.
Solution Approach 2:
The patent introduces a toxin-antitoxin system as an intermediary mechanism. The toxin gene is integrated into the chromosome and the antitoxin gene is on the plasmid. This intermediary system mediates plasmid stability by creating a biological dependency relationship between the plasmid and cell survival, replacing the direct antibiotic-plasmid selection mechanism.
2Object-affected harmful factors
If toxin gene is introduced into bacterial chromosome with plasmid-borne antitoxin gene, then antibiotic-free selection is achieved, but the process becomes complex with multiple genes and plasmids required
Solution Approach 1:
The patent merges the selection function and plasmid stability function into a single integrated toxin-antitoxin system. The toxin is chromosomally encoded and the antitoxin is plasmid-encoded, creating a unified biological control mechanism that simultaneously achieves antibiotic-free selection and plasmid maintenance without requiring separate systems.
Solution Approach 2:
The toxin-antitoxin system serves multiple functions simultaneously: it provides antibiotic-free selection pressure, maintains plasmid stability, and enables straightforward transformation protocols. This multi-functional system replaces what would otherwise require separate mechanisms for each function, reducing overall process complexity despite the genetic elements involved.
3Object-affected harmful factors
If essential gene is deleted from genome and complemented by expression plasmid, then antibiotic-free maintenance is achieved, but bacteria can only be propagated at specific temperatures which is inferior for manufacturing
Solution Approach 1:
The patent extracts the temperature sensitivity constraint from the system by using a toxin-antitoxin mechanism rather than temperature-sensitive essential gene complementation. This removes the restriction on propagation temperature while maintaining antibiotic-free plasmid stability through the biochemical toxin-antitoxin interaction that operates independently of temperature conditions.
Solution Approach 2:
The patent changes the control parameter from temperature (in previous approaches) to the presence/absence of the antitoxin gene product. This parameter change allows the system to function across a wide temperature range suitable for industrial manufacturing, while still providing effective plasmid maintenance through the biological control mechanism.
4Ease of operation
If selection markers are used in expression plasmid, then transformed bacteria can be selected, but the use of antibiotics is excessive and causes environmental problems
Solution Approach 1:
The patent converts the potentially harmful antibiotic selection mechanism into a beneficial toxin-antitoxin system. The toxin, when unopposed by the antitoxin, creates selective pressure similar to antibiotics but without the harmful environmental effects. The system uses the toxin's harmful potential selectively only against plasmid-free cells, while plasmid-containing cells are protected by the antitoxin, achieving selection without antibiotic pollution.
Data Source
AI summary
The present invention relates to means for recombinant manufacture. In particular, it relates to a recombinant bacterial cell comprising in its genome (i) at least one endogenous essential gene which is inactivated, and (ii) at least one introduced copy of the said at least one essential gene, wherein said introduced copy is operatively linked to a heterologous expression control sequence being inducible by an inducer molecule, such that the expression of said essential gene in the recombinant bacterial cell is dependent on the presence of said inducer molecule. The present invention, further relates to a method for generating the recombinant bacterial cell, a method for recombinant manufacture of a compound of interest and the use of a recombinant bacterial cell for the manufacture of a compound of interest. Moreover, the invention provides a kit for recombinant manufacture of a compound of interest.